Intact mass and middle-down analysis for mAbs
收藏国家人口健康科学数据中心2026-06-01 收录
官方服务：
资源简介：
An integrated strategy has been developed to characterize Trastuzumab and Adalimumab structural heterogeneity, which has prominent advantages in fast sample preparation with minimal artifacts, and complementary information obtained from intact mass and middle-down analyses.
提供机构：
北京蛋白质组研究中心创建时间：
2020-09-03
